Skip to main content
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Search
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIOpen mainmenu item
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsOpen mainmenu item
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
  • Facilities and InstrumentsOpen mainmenu item
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesOpen mainmenu item
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsOpen mainmenu item
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

You are here:

  1. PSI Home
  2. Labs & User Services
  3. PSD
  4. COVID-19
  5. COVID-19 Highlights

Secondary navigation

Photon Science Division

  • About PSD
    • Organisational Structure
    • Photon Science Advisory Committee
  • People
  • Laboratories
  • Facilities
  • Industrial Services
  • Projects
    • ERC Synergy project HERO: Hidden Entangled and Resonating Orders
    • SLS 2.0
  • European and International Collaborations
    • BEATS
    • CALIPSOplus
    • ExPaNDS
    • LEAPS
    • Lightsources
    • LEAPS-INNOV
    • ReMade@ARI
  • Scientific Highlights and News
  • Events Photon Science Division
    • Events Photon Science Division (archive)
  • Publications

COVID-19 Highlights

24 January 2022
Thomas Mortelmans

New, better coronavirus rapid test

Media Releases Health Innovation Medical Science Research on Covid-19

The test identifies different virus variants and improves disease prognosis.

Read more
30 August 2021
nanobodies

Nanobodies against SARS-CoV-2

In a study published in EMBO Journal, researchers at the Max Planck Institute for Biophysical Chemistry, Göttingen, Germany, developed nanobodies that efficiently block the coronavirus SARS-CoV-2 and its variants. The high resolution structural characterization was performed at the X10SA crystallography beamline at the Swiss Light Source.

Read more
5 July 2021
Corona Dunkelziffer

Tracking down unreported Coronavirus cases

Research Using Synchrotron Light Biology Health Innovation Medical Science Research on Covid-19

The University Hospital of Zurich uses proteins made at PSI for Europe’s first large-scale serology study on coronavirus prevalence in Switzerland.

Read more
22 June 2021
 (Photo:Shutterstock.com)

PSI: advancing in the fight against Covid-19

Health Innovation Medical Science Research on Covid-19

Crystal structure analysis, computer models, cell cultures – to pursue research on Sars-CoV-2, PSI is exploring many avenues. An overview.

Read more
3 June 2021
SARS-CoV-2_orf9b

Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions

In a study published in Nature Communications, researchers at the NHC Key Laboratory of Systems Biology of Pathogens in Beijing, China, in collaboration with the Paul Scherrer Institut characterize the interactions of SARS-CoV-2 orf9b and human TOM70 biochemically, and they determine the 2.2 Å crystal structure of the TOM70 cytosolic domain with a bound SARS-CoV-2 orf9b peptide.

Read more
11 May 2021
Teaser Remdesivir

How remdesivir works against the coronavirus

Health Innovation Medical Science Research on Covid-19

Researchers at Goethe University Frankfurt, in cooperation with the PSI have probably discovered another, previously unknown mechanism of action of the antiviral remdesivir.

Read more
8 March 2021
Teaser covid research

Forschung zu Covid-19 am Paul Scherrer Institut

Forschung zu Covid-19

Während viele Bereiche des Lebens eingeschränkt sind, bleiben wichtige Forschungsanlagen am PSI in Betrieb. 

Read more
31 August 2020
May Sharpe

A question of binding

Research Using Synchrotron Light Large Research Facilities Biology Health Innovation Research on Covid-19

At PSI, researchers are screening molecule fragments to see if these bind to important proteins of the coronavirus SARS-CoV-2 and thus have the potential to disable it. They are hoping the many individual pieces of information will yield an answer as to what an effective drug might look like.

Read more
30 July 2020
Dr. May Elizabeth Sharpe

Covid-19 research: Anti-viral strategy with double effect

Research Using Synchrotron Light Biology Health Innovation Research on Covid-19

Frankfurt scientists identify a possible weakness of the SARS-CoV-2 virus. They carried out part of their measurements at PSI's Swiss Light Source SLS. The research results are published this week in the scientific journal Nature.

Read more
15 May 2020
Dikic lab

First MX results of the priority COVID-19 call

The Dikic group at the Goethe University in Frankfurt am Main, Germany has published the first results following the opening of the "PRIORITY COVID-19 Call” at SLS. 

Read more
31 March 2020
covid-19

SLS MX beamtime update

Update of the SLS MX beamline operation during the COVID-19 period

Read more
17 December 2021
COVID call

Priority access call for work on combating COVID-19 continues

On January 30th, 2020, the WHO declared the recent outbreak of coronavirus disease 2019 (COVID-19), a public health emergency of international concern. It declared that there is an urgent need to improve our understanding of the newly identified virus and its possible future evolution as well as to contain the spread; to develop precise diagnostics and treatment, and to improve the public health response and patient care.

The COVID priority access call continues and is still open in 2022.

Read more

Sidebar

top

Footer

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Switzerland

Telephone: +41 56 310 21 11
Telefax: +41 56 310 21 99

How to find us
Contact

Visitor Centre psi forum
School Lab iLab (in German)
Center for Proton Therapy
PSI Education Centre
PSI Guest House
PSI Gastronomie (in German)
psi forum shop

Service & Support

  • Phone Book
  • User Office
  • Accelerator Status
  • PSI Publications
  • Suppliers
  • E-Billing
  • Computing
  • Safety (in German)

Career

  • Working at PSI
  • Job Opportunities
  • Training and further education
  • Career Center
  • Vocational Training (in German)
  • PSI Education Center

For the media

  • PSI in brief
  • Facts and Figures
  • Media corner
  • Media Releases
  • Social Media

Follow us: Twitter (in English) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Imprint
  • Terms and Conditions
  • Editors' login